Washington Homeopathic Cistus Canadensis pills fail quality identification testing
Washington Homeopathic Products is recalling Cistus Canadensis homeopathic pills in multiple potencies because they failed out-of-specification identification testing. The recall affects 17 bottles distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving a labeling or product-identity issue (failed identification testing). No illnesses or injuries have been reported. The hazard is testing-based and precautionary in nature, making it a moderate-severity issue appropriate for Class II recalls without reported adverse health events.
Plain-English summary
Washington Homeopathic Products, Inc. is recalling Cistus Canadensis 6X, 10X, 15X, and 30X sucrose/lactose pills due to out-of-specification test results obtained during identification testing using HPTLC (high-performance thin-layer chromatography) analysis.
The recall covers Lot #28638 with an expiration date of 08/17/2026, distributed nationwide in the USA. The affected product was packaged in multiple configurations across different potencies, totaling 17 bottles.
Consumers who have purchased this product should not use it and should return it to the place of purchase or contact Washington Homeopathic Products for further instructions. Healthcare providers and retailers should stop dispensing or selling this product.
This is a Class II recall issued by the FDA.
The recalled product
- Product
- Cistus Canadensis 6X, 10X, 15X, 30X, Coldness* Sucrose/Lactose Pills, 6X Packaged as a) 1 OZ, UPC 7 40640 28177 2, b) 4 dr, UPC 7 40640 28173 4; 10X Packaged as c) 4 dr; 15X Packaged as d) 1 OZ; 30X Packaged as e) 2 Dram, UPC 7 40640 28171 0, f) 4 dr, UPC 7 40640 28175 8; WHP Hom
- Manufacturer
- Washington Homeopathic Products, Inc.
- Category
- Drug — Homeopathic Medicine
- Hazard
- product-identity-failure
- failed-identification-testing
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 28638
- EXP 08/17/2026
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27